456 related articles for article (PubMed ID: 8463728)
41. Use of a different buffer system in the phenolic glycolipid-I ELISA.
Sticht-Groh V; Alvarenga AE; Vettom L; von Ballestrem W
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):570-4. PubMed ID: 1299712
[TBL] [Abstract][Full Text] [Related]
42. Role of PGL-I antibody detection in the diagnosis of pure neural leprosy.
Jardim MR; Antunes SL; Simons B; Wildenbeest JG; Nery JA; Illarramendi X; Moraes MO; Martinez AN; Oskam L; Faber WR; Sarno EN; Sampaio EP; Bührer-Sékula S
Lepr Rev; 2005 Sep; 76(3):232-40. PubMed ID: 16248210
[TBL] [Abstract][Full Text] [Related]
43. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients.
Britton WJ; Garsia RJ; Basten A
Aust N Z J Med; 1987 Dec; 17(6):568-73. PubMed ID: 3328975
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of monitoring antibodies to PGL-I in armadillos experimentally infected with M. leprae.
Truman RW; Morales MJ; Shannon EJ; Hastings RC
Int J Lepr Other Mycobact Dis; 1986 Dec; 54(4):556-9. PubMed ID: 3546545
[TBL] [Abstract][Full Text] [Related]
45. Seroepidemiological study of leprosy in a highly endemic population of south India based on an ELISA using synthetic PGL-I.
Krishnamurthy P; Rao PS; Reddy BN; Subramanian M; Dhandayudapani S; Bhatia V; Neelan PN; Dutta A
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):426-31. PubMed ID: 1890366
[TBL] [Abstract][Full Text] [Related]
46. Recognition of phenolic glycolipid-I (Mycobacterium leprae) and sulfolipid-I (M. tuberculosis) by serum from Mexican patients with leprosy or tuberculosis.
Rojas-Espinosa O; Luna-Herrera J; Arce-Paredes P
Int J Tuberc Lung Dis; 1999 Dec; 3(12):1106-12. PubMed ID: 10599015
[TBL] [Abstract][Full Text] [Related]
47. A study on the reproducibility of two serological assays for detection of Mycobacterium leprae infection.
Parkash O
Int J Lepr Other Mycobact Dis; 2001 Mar; 69(1):46-8. PubMed ID: 11480319
[No Abstract] [Full Text] [Related]
48. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
49. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
[TBL] [Abstract][Full Text] [Related]
50. Higher specificity in the serodiagnosis of leprosy by combined titration of antiphenolic glycolipid-I and antiphospholipid antibodies.
Fiallo P; Cardo PP; Nunzi E
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):464-6. PubMed ID: 8228448
[No Abstract] [Full Text] [Related]
51. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy.
Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ
Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457
[TBL] [Abstract][Full Text] [Related]
52. An enzyme immunoassay titrating IgM antibody against phenolic glycolipid for diagnosis of lepromatous leprosy.
Ralhan R; Band AH; Roy A; Hajini GH; Sharma AK; Talwar GP
Indian J Med Res; 1985 Aug; 82():110-5. PubMed ID: 3902635
[No Abstract] [Full Text] [Related]
53. Can anti-PGL-1 and anti-NDO-LID-1 antibody titers be used to predict the risk of reactions in leprosy patients?
Devides AC; Rosa PS; de Faria Fernandes Belone A; Coelho NMB; Ura S; Silva EA
Diagn Microbiol Infect Dis; 2018 Jul; 91(3):260-265. PubMed ID: 29669693
[TBL] [Abstract][Full Text] [Related]
54. Performance of recombinant ESAT-6 antigen (ML0049) for detection of leprosy patients.
Parkash O; Pandey R; Kumar A; Kumar A
Lett Appl Microbiol; 2007 May; 44(5):524-30. PubMed ID: 17451520
[TBL] [Abstract][Full Text] [Related]
55. Appraisal of two Mycobacterium leprae-specific serological assays for monitoring chemotherapy in lepromatous (LL/BL) leprosy patients.
Sinha S; McEntegart A; Girdhar BK; Bhatia AS; Sengupta U
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):24-32. PubMed ID: 2659698
[TBL] [Abstract][Full Text] [Related]
56. Immunological response to homologous and heterologous phenolic glycolipid antigens in tuberculosis and leprosy.
Torgal-Garcia J; Papa F; David HL
Acta Leprol; 1989; 7 Suppl 1():102-6. PubMed ID: 2503962
[TBL] [Abstract][Full Text] [Related]
57. Rapid serodiagnosis for leprosy--a preliminary study on latex agglutination test.
Wu QX; Ye GY; Yin YP; Li XY; Liu Q; Wei WH
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):328-33. PubMed ID: 2198316
[TBL] [Abstract][Full Text] [Related]
58. ML0405 and ML2331 are antigens of Mycobacterium leprae with potential for diagnosis of leprosy.
Reece ST; Ireton G; Mohamath R; Guderian J; Goto W; Gelber R; Groathouse N; Spencer J; Brennan P; Reed SG
Clin Vaccine Immunol; 2006 Mar; 13(3):333-40. PubMed ID: 16522774
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of four semi-synthetic Mycobacterium leprae antigens with sera from healthy populations in endemic and non-endemic areas.
Douglas JT; Steven LM; Hirsch DS; Fujiwara T; Nelson KE; Madarang MG; Cellona RV
Lepr Rev; 1992 Sep; 63(3):199-210. PubMed ID: 1406016
[TBL] [Abstract][Full Text] [Related]
60. Serological monitoring of the response to chemotherapy in leprosy patients.
Roche PW; Britton WJ; Failbus SS; Neupane KD; Theuvenet WJ
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):35-43. PubMed ID: 8326179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
